0000950170-24-068993.txt : 20240604
0000950170-24-068993.hdr.sgml : 20240604
20240604192139
ACCESSION NUMBER: 0000950170-24-068993
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simon Mark
CENTRAL INDEX KEY: 0001400717
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39103
FILM NUMBER: 241020187
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cabaletta Bio, Inc.
CENTRAL INDEX KEY: 0001759138
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 ARCH STREET
STREET 2: SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (267) 759-3100
MAIL ADDRESS:
STREET 1: 2929 ARCH STREET
STREET 2: SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
ownership.xml
4
X0508
4
2024-06-03
0001759138
Cabaletta Bio, Inc.
CABA
0001400717
Simon Mark
C/O CABALETTA BIO, INC.
2929 ARCH STREET, SUITE 600
PHILADELPHIA
PA
19104
true
false
false
false
false
Stock Option (Right to Buy)
10.01
2024-06-03
4
A
false
22000
0.00
A
2034-06-02
Common Stock
22000
22000
D
This option shall vest in full upon the earlier of (i) June 3, 2025 or (ii) the date of the next annual meeting of the Corporation's stockholders.
/s/ Michael Gerard, Attorney-in-Fact
2024-06-04